DYNE THERAPEUTICS INC. - COMMON STOCK
15.68
05-February-25 16:45:00
15 minutes delayed
Stocks
+0.89
+6.02%
Today's range
14.80 - 16.01
ISIN
N/A
Source
NASDAQ
-
Dyne Therapeutics Reports Second Quarter 2021 Financial Results and Business Highlights
05 Aug 2021 07:30:01 By Nasdaq GlobeNewswire
-
25 Jun 2021 07:30:00 By Nasdaq GlobeNewswire
-
Dyne Therapeutics Announces Chief Scientific Officer Transition
02 Jun 2021 16:05:00 By Nasdaq GlobeNewswire
-
Dyne Therapeutics to Present at Jefferies Virtual Healthcare Conference
26 May 2021 07:30:00 By Nasdaq GlobeNewswire
-
Dyne Therapeutics Reports First Quarter 2021 Financial Results and Business Highlights
06 May 2021 07:29:00 By Nasdaq GlobeNewswire
-
Dyne Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Recent Highlights
04 Mar 2021 07:35:00 By Nasdaq GlobeNewswire
-
Dyne Therapeutics Appoints Wildon Farwell, M.D., MPH, as Chief Medical Officer
04 Mar 2021 07:25:00 By Nasdaq GlobeNewswire
-
08 Feb 2021 07:30:00 By Nasdaq GlobeNewswire
-
Dyne Therapeutics Announces Pricing of $168 Million Public Offering
20 Jan 2021 20:05:29 By Nasdaq GlobeNewswire
-
10 Jan 2021 15:00:00 By Nasdaq GlobeNewswire
-
Dyne Therapeutics to Present at 39th Annual J.P. Morgan Healthcare Conference
05 Jan 2021 07:30:00 By Nasdaq GlobeNewswire